227 related articles for article (PubMed ID: 37500963)
61. FDG-PET for axillary lymph node staging in primary breast cancer.
Crippa F; Gerali A; Alessi A; Agresti R; Bombardieri E
Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S97-102. PubMed ID: 15133635
[TBL] [Abstract][Full Text] [Related]
62. Dynamic contrast-enhanced and diffusion-weighted MRI of invasive breast cancer for the prediction of sentinel lymph node status.
Choi EJ; Youk JH; Choi H; Song JS
J Magn Reson Imaging; 2020 Feb; 51(2):615-626. PubMed ID: 31313393
[TBL] [Abstract][Full Text] [Related]
63. Diagnostic value of Platelet/lymphocyte Ratio (PLR) for predicting sentinel axillary lymph node positivity in early-stage breast cancer compared with ultrasonography.
Morkavuk ŞB; Kocaöz S; Korukluoğlu B
Int J Clin Pract; 2021 Dec; 75(12):e14939. PubMed ID: 34605138
[TBL] [Abstract][Full Text] [Related]
64. The value of the improved percutaneous and intravenous contrast-enhanced ultrasound diagnostic classification in sentinel lymph nodes of breast cancer.
Huang C; Luo J; Shan Z; Zhen T; Li J; Ma Q; Wei L; Liang J; Xie X; Zheng Y
Quant Imaging Med Surg; 2024 Mar; 14(3):2391-2404. PubMed ID: 38545047
[TBL] [Abstract][Full Text] [Related]
65. Contrast-Enhanced Ultrasound-Guided Fine-Needle Aspiration for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer.
Zhong J; Sun DS; Wei W; Liu X; Liu J; Wu X; Zhang Y; Luo H; Li Y
Ultrasound Med Biol; 2018 Jul; 44(7):1371-1378. PubMed ID: 29631800
[TBL] [Abstract][Full Text] [Related]
66. Total tumor load assessed by one-step nucleic acid amplification assay as an intraoperative predictor for non-sentinel lymph node metastasis in breast cancer.
Nabais C; Figueiredo J; Lopes P; Martins M; Araújo A
Breast; 2017 Apr; 32():33-36. PubMed ID: 28030783
[TBL] [Abstract][Full Text] [Related]
67. [Preliminary study on a new sentinel lymphoscintigraphy agent 99mTc-Rituximab for breast patient].
Wang XJ; Lin BH; Yang Z; Ouyang T; Li JF; Xu B; Zhang Y; Zhang MY
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):200-3. PubMed ID: 16875605
[TBL] [Abstract][Full Text] [Related]
68. Advanced diagnostic imaging of sentinel lymph node in early stage breast cancer.
Li P; Sun D
J Clin Ultrasound; 2022 Mar; 50(3):415-421. PubMed ID: 35092313
[TBL] [Abstract][Full Text] [Related]
69. Enhanced axillary assessment using intradermally injected microbubbles and contrast-enhanced ultrasound (CEUS) before neoadjuvant systemic therapy (NACT) identifies axillary disease missed by conventional B-mode ultrasound that may be clinically relevant.
Cox K; Dineen N; Taylor-Phillips S; Sharma N; Harper-Wynne C; Allen D; Weeks J; Chalmers R; Akolekar D; Burcombe R; Jyothirmayi R; Sever A
Breast Cancer Res Treat; 2021 Jan; 185(2):413-422. PubMed ID: 33029707
[TBL] [Abstract][Full Text] [Related]
70. Hookwire-guided Sentinel Lymph Node Biopsy Using Contrast-enhanced Ultrasonography Followed by a One-step Nucleic Acid Amplification (OSNA) Assay for Breast Cancer.
Miyake T; Shimazu K; Tanei T; Naoi Y; Kagara N; Shimoda M; Kim SJ; Noguchi S
Anticancer Res; 2019 Nov; 39(11):6183-6192. PubMed ID: 31704846
[TBL] [Abstract][Full Text] [Related]
71. Prediction of non-sentinel lymph node metastasis in early breast cancer by assessing total tumoral load in the sentinel lymph node by molecular assay.
Espinosa-Bravo M; Sansano I; Pérez-Hoyos S; Ramos M; Sancho M; Xercavins J; Rubio IT; Peg V
Eur J Surg Oncol; 2013 Jul; 39(7):766-73. PubMed ID: 23607911
[TBL] [Abstract][Full Text] [Related]
72. Contrast-enhanced ultrasound for sentinel lymph node mapping in the routine staging of canine mast cell tumours: A feasibility study.
Fournier Q; Thierry F; Longo M; Malbon A; Cazzini P; Bisson J; Woods S; Liuti T; Bavcar S
Vet Comp Oncol; 2021 Sep; 19(3):451-462. PubMed ID: 32840038
[TBL] [Abstract][Full Text] [Related]
73. [Risk factors of non-sentinel lymph node metastasis and performance of MSKCC nomogramin breast cancer patients with metastatic sentinel lymph node].
Huang J; Chen X; Fei X; Huang O; Wu J; Zong Y; Zhu L; He J; Chen W; Li Y; Shen K
Zhonghua Wai Ke Za Zhi; 2015 Dec; 53(12):941-6. PubMed ID: 26850667
[TBL] [Abstract][Full Text] [Related]
74. Preoperative Axillary US in Early-Stage Breast Cancer: Potential to Prevent Unnecessary Axillary Lymph Node Dissection.
Kim GR; Choi JS; Han BK; Lee JE; Nam SJ; Ko EY; Ko ES; Lee SK
Radiology; 2018 Jul; 288(1):55-63. PubMed ID: 29558291
[TBL] [Abstract][Full Text] [Related]
75. Contrast-Enhanced Ultrasound With Perflubutane for Sentinel Lymph Node Mapping in Cutaneous Melanoma: A Pilot Study.
Bertelsen C; King KG; Swanson M; Duddalwar V; Pepper JP
Laryngoscope; 2019 May; 129(5):1117-1122. PubMed ID: 30284307
[TBL] [Abstract][Full Text] [Related]
76. A Novel Predictive Nomogram including Serum Lipoprotein a Level for Nonsentinel Lymph Node Metastases in Chinese Breast Cancer Patients with Positive Sentinel Lymph Node Metastases.
Fang Z; Wang R; Yang C; Wang D; Chen W; Lin B; Gong D; Li S; Liang J; Liang X; Zeng C; Li J; Wang K; Lv W
Dis Markers; 2021; 2021():7879508. PubMed ID: 34853623
[TBL] [Abstract][Full Text] [Related]
77. Sentinel lymph node biopsy in oral cavity cancer using indocyanine green: A systematic review and meta-analysis.
Chen Y; Xiao Q; Zou W; Xia C; Yin H; Pu Y; Wang Y; Zhang K
Clinics (Sao Paulo); 2021; 76():e2573. PubMed ID: 34287476
[TBL] [Abstract][Full Text] [Related]
78. Adding contrast-enhanced ultrasound markers to conventional axillary ultrasound improves specificity for predicting axillary lymph node metastasis in patients with breast cancer.
Du LW; Liu HL; Gong HY; Ling LJ; Wang S; Li CY; Zong M
Br J Radiol; 2021 Feb; 94(1118):20200874. PubMed ID: 32976019
[TBL] [Abstract][Full Text] [Related]
79. Development and validation of a pre- and intra-operative scoring system that distinguishes between non-advanced and advanced axillary lymph node metastasis in breast cancer with positive sentinel lymph nodes: a retrospective study.
Murata T; Watase C; Shiino S; Kurita A; Ogawa A; Jimbo K; Iwamoto E; Yoshida M; Takayama S; Suto A
World J Surg Oncol; 2022 Sep; 20(1):314. PubMed ID: 36171615
[TBL] [Abstract][Full Text] [Related]
80. Identification of sentinel lymph nodes by contrast-enhanced ultrasonography with Sonazoid in patients with breast cancer: a feasibility study in three hospitals.
Shimazu K; Ito T; Uji K; Miyake T; Aono T; Motomura K; Naoi Y; Shimomura A; Shimoda M; Kagara N; Kim SJ; Noguchi S
Cancer Med; 2017 Aug; 6(8):1915-1922. PubMed ID: 28766883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
